Oppenheimer upgrades BioMarin on long term outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq hits near three-month low as Amazon, Intel rattle AI trade
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 58.29 +0.80 (1.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $57.49 | 52 Week High | $108.96 | |||
| Open | $58.40 | 52 Week Low | $62.12 | |||
| Day High | $59.37 | P/E | N/A | |||
| Day Low | $57.86 | EPS | $-1.27 | |||
| Volume | 832,923 | |||||
